{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:07:34Z","timestamp":1788890854744,"version":"build-2803163510"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic bone disorder associated with considerable clinical, economic, and societal impacts on patients, their caregivers, and the healthcare system. The aim of this study was to update the estimated prevalence of FOP in France, characterize the FOP patient population and impact of the disease, assess associated mortality rates, and quantify healthcare resource utilization and socioeconomic costs for individuals with FOP. An observational, retrospective case-control study was conducted using linked data for individuals with FOP from the French National Rare Diseases Registry and the French National Healthcare System Database (SNDS). Results were compared with the SNDS for a control group of individuals with any disease other than FOP. Prevalence of FOP was estimated at 1.39 per million. Data were available for 77 individuals with FOP and 769 controls without FOP. Of 70 individuals with FOP and a social security number at the index date, 50.0% (n\u2009=\u200935\/70) were female, and the mean (SD) age was 25.3 (15.7) yr. Comorbidities were consistently more prevalent in individuals with FOP than in people without FOP. Consultations with general practitioners and non-physician healthcare providers, hospitalizations, and use of medical devices and treatments were significantly greater in individuals with vs without FOP (p\u2009&amp;lt;\u2009.05 for all). Mean total annual healthcare expenditure was more than 10 times greater in individuals with FOP than those without FOP from a societal perspective (largely driven by outpatient costs) and 14 times greater from a payer perspective. Overall survival was significantly worse in individuals with FOP than in individuals without (p\u2009&amp;lt;\u2009.0001). Findings from this study reinforce the clinical, economic, and societal impacts associated with FOP. Improving disease awareness and developing new interventions to support a reduction in these impacts should be considered key priorities for the FOP community and healthcare providers.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag125","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:25:26Z","timestamp":1786361126000},"source":"Crossref","is-referenced-by-count":0,"title":["The socioeconomic impacts of fibrodysplasia ossificans progressiva: evidence from a retrospective case-control study in France"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-0298","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Baujat","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine G\u00e9nomique des Maladies Rares, Universit\u00e9 Paris Cit\u00e9, INSERM UMR 1163, Institut Imagine, H\u00f4pital Necker-Enfants malades , Paris 75015, \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2680","authenticated-orcid":false,"given":"St\u00e9phane","family":"Bou\u00e9e","sequence":"additional","affiliation":[{"name":"CEMKA, Boulevard Mar\u00e9chal Joffre, Bourg-La-Reine 92340,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2655-9512","authenticated-orcid":false,"given":"Oyinkan","family":"Solanke","sequence":"additional","affiliation":[{"name":"Medical Affairs Rare Disease \/ Global HEOR, Medical Affairs Rare Disease \/ Global HEOR, Ipsen , London W2 1AF ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-4022","authenticated-orcid":false,"given":"Kim","family":"Croskery","sequence":"additional","affiliation":[{"name":"Medical Affairs Rare Disease \/ Global HEOR, Medical Affairs Rare Disease \/ Global HEOR, Ipsen , London W2 1AF ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0729-7667","authenticated-orcid":false,"given":"Justin","family":"Kirion","sequence":"additional","affiliation":[{"name":"CEMKA, Boulevard Mar\u00e9chal Joffre, Bourg-La-Reine 92340,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-9856","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Cormier-Daire","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine G\u00e9nomique des Maladies Rares, Universit\u00e9 Paris Cit\u00e9, INSERM UMR 1163, Institut Imagine, H\u00f4pital Necker-Enfants malades , Paris 75015, \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-8539","authenticated-orcid":false,"given":"Anne-Sophie","family":"Jannot","sequence":"additional","affiliation":[{"name":"Banque Nationale de Donn\u00e9es Maladies Rares (Banque Nationale de Donn\u00e9es Maladies Rares (BNDMR), Greater Paris University Hospitals (APHP) , Paris 75012, \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7422-0022","authenticated-orcid":false,"given":"Viviane","family":"Jeanbat","sequence":"additional","affiliation":[{"name":"CEMKA, Boulevard Mar\u00e9chal Joffre, Bourg-La-Reine 92340,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7684-2405","authenticated-orcid":false,"given":"Thomas","family":"Funck-Brentano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lariboisi\u00e8re Hospital, APHP, Nord, Universit\u00e9 Paris Cit\u00e9 , Paris 75010, \u00a0","place":["France"]},{"name":"BIOSCAR, Universit\u00e9 Paris Cit\u00e9, Inserm, Paris 75010, \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026090813220445900_ref1","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"2","author":"Kaplan","year":"2021","journal-title":"Proc Int Clin Counc FOP"},{"issue":"1","key":"2026090813220445900_ref2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-017-0674-5","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases","volume":"12","author":"Baujat","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2026090813220445900_ref3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000365770","article-title":"Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation","volume":"5","author":"H\u00fcning","year":"2014","journal-title":"Mol Syndromol"},{"issue":"1","key":"2026090813220445900_ref4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1302\/0301-620X.64B1.7068725","article-title":"Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients","volume":"64","author":"Connor","year":"1982","journal-title":"J Bone Joint Surg Br"},{"issue":"3","key":"2026090813220445900_ref5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"2026090813220445900_ref6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s12325-022-02096-3","article-title":"\"I can't take off my shirt or do my own hair\"-a qualitative investigation of the symptoms and impact experience of children and adolescents with fibrodysplasia ossificans progressiva (FOP)","volume":"39","author":"Markowitz","year":"2022","journal-title":"Adv Ther"},{"issue":"6","key":"2026090813220445900_ref7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/09638288.2017.1405083","article-title":"Longitudinal study of the activities of daily living and quality of life in Japanese patients with fibrodysplasia ossificans progressiva","volume":"41","author":"Nakahara","year":"2019","journal-title":"Disabil Rehabil"},{"key":"2026090813220445900_ref8","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.bone.2020.115274","article-title":"Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) association global registry","volume":"134","author":"Pignolo","year":"2020","journal-title":"Bone."},{"issue":"8","key":"2026090813220445900_ref9","doi-asserted-by":"publisher","first-page":"e10181","DOI":"10.1002\/jbm4.10181","article-title":"Longitudinal evaluation of pain, flare-up, and emotional health in fibrodysplasia ossificans progressiva: analyses of the international FOP registry","volume":"3","author":"Peng","year":"2019","journal-title":"JBMR Plus"},{"issue":"1","key":"2026090813220445900_ref10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.29245\/2572-9411\/2021\/1.1200","article-title":"Caregiver support in fibrodysplasia ossificans progressiva","volume":"6","author":"Al Mukaddam","year":"2021","journal-title":"J Rare Dis Res Treat"},{"issue":"3","key":"2026090813220445900_ref11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2026090813220445900_ref12","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.gim.2022.08.013","article-title":"The natural history of fibrodysplasia ossificans progressiva: a prospective, global 36-month study","volume":"24","author":"Pignolo","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"2026090813220445900_ref13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/jmg.19.1.35","article-title":"Genetic aspects of fibrodysplasia ossificans progressiva","volume":"19","author":"Connor","year":"1982","journal-title":"J Med Genet"},{"issue":"2","key":"2026090813220445900_ref14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jmg.16.2.147","article-title":"Paternal age effect in fibrodysplasia ossificans progressiva","volume":"16","author":"Rogers","year":"1979","journal-title":"J Med Genet"},{"issue":"1","key":"2026090813220445900_ref15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1086\/302724","article-title":"Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31","volume":"66","author":"Feldman","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"3\u20134","key":"2026090813220445900_ref16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1385\/BMM:3:3-4:201","article-title":"The genetics of fibrodysplasia ossificans progressiva","volume":"3","author":"Shore","year":"2005","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"2","key":"2026090813220445900_ref17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva. An endochondral process","volume":"75","author":"Kaplan","year":"1993","journal-title":"J Bone Joint Surg Am"},{"key":"2026090813220445900_ref18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cytogfr.2015.12.007","article-title":"Common mutations in ALK2\/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders","volume":"27","author":"Pacifici","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2026090813220445900_ref19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2013.09.002","article-title":"The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases","volume":"57","author":"Zhang","year":"2013","journal-title":"Bone."},{"issue":"3","key":"2026090813220445900_ref20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum Mutat"},{"issue":"3","key":"2026090813220445900_ref21","first-page":"53","article-title":"A literature review of HRQoL and prevalence of fibrodysplasia ossificans progressiva","volume":"13","author":"Mahapatra","year":"2023","journal-title":"J Appl Pharm Sci"},{"issue":"2","key":"2026090813220445900_ref22","doi-asserted-by":"publisher","first-page":"033","DOI":"10.23937\/2643-4571\/1710033","article-title":"A case of fibrodysplasia ossificans progressiva in Kenya","volume":"4","author":"Mwende","year":"2021","journal-title":"Int J Rare Dis Disord"},{"issue":"6","key":"2026090813220445900_ref23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11832-015-0704-6","article-title":"Quality of life of patients with fibrodysplasia ossificans progressiva","volume":"9","author":"Ortiz-Agapito","year":"2015","journal-title":"J Child Orthop"},{"key":"2026090813220445900_ref24","volume-title":"The FOP Registry","author":"FOP Registry","year":"2025"},{"issue":"8","key":"2026090813220445900_ref25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/14737167.2022.2115360","article-title":"The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey","volume":"22","author":"Al Mukaddam","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"2026090813220445900_ref26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13023-021-01983-2","article-title":"Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization","volume":"16","author":"Pignolo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026090813220445900_ref27","article-title":"FOP prevalence study released","author":"International FOP Association (IFOPA)","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2026090813220445900_ref28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12891-020-3170-3","article-title":"Serum osteocalcin level is associated with the mortality in Chinese patients with fibrodysplasia ossificans progressiva aged \u2264\u226418\u2009\u2009years at diagnosis","volume":"21","author":"She","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"2026090813220445900_ref29","author":"Fili\u00e8re des Maladies Rares Abdomino-Thoraciques (FIMATHO)","year":"2025"},{"issue":"suppl 3","key":"2026090813220445900_ref30","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.1016\/j.jval.2018.09.2214","article-title":"SNDS, the French nationwide claims database: a powerful tool for pharmacoeconomy and pharmacoepidemiology","volume":"21","author":"Blin","year":"2018","journal-title":"Value Health"},{"issue":"6","key":"2026090813220445900_ref31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.therap.2024.05.003","article-title":"Use of the French National Health Data System (SNDS) in pharmacoepidemiology: a systematic review in its maturation phase","volume":"79","author":"Maillard","year":"2024","journal-title":"Therapie."},{"issue":"2","key":"2026090813220445900_ref32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20517\/rdodj.2022.08","article-title":"Rare diseases: specific challenges for sustainable accessibility of treatments for patients","volume":"1","author":"Cortial","year":"2022","journal-title":"Rare Dis Orphan Drugs J"},{"key":"2026090813220445900_ref33","author":"The National Institute of Statistics and Economic Studies (L\u2019Institut national de la statistique et des \u00e9tudes \u00e9conomiques)","year":"2025"},{"issue":"158","key":"2026090813220445900_ref34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2026090813220445900_ref35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson Comorbidity Index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med Care"},{"key":"2026090813220445900_ref36","article-title":"CEMARA: a web dynamic application within a N-tier architecture for rare diseases","author":"Messiaen"},{"issue":"2","key":"2026090813220445900_ref37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2572-9411\/2020\/2.1196","article-title":"Epidemiology of the global fibrodysplasia ossificans progressiva (FOP) community","volume":"5","author":"Liljesthr\u00f6m","year":"2020","journal-title":"J Rare Dis Res Treat"},{"key":"2026090813220445900_ref38","author":"Eurostat","year":"2025"},{"key":"2026090813220445900_ref39","article-title":"Mortality in the United States, 2022","author":"Kochanek","journal-title":"NCHS Data Brief"},{"issue":"6","key":"2026090813220445900_ref40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1089\/jayao.2024.0136","article-title":"Trends in the incidence of cancer among adolescents and young adults between 2000 and 2020: a study based on French population-based registry data","volume":"14","author":"Desandes","year":"2025","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"1","key":"2026090813220445900_ref41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/jayao.2020.0017","article-title":"Cancer among adolescents and young adults between 2000 and 2016 in France: incidence and improved survival","volume":"10","author":"Raze","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"1","key":"2026090813220445900_ref42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.31138\/mjr.210524.mta","article-title":"All restricted spines are not spondyloarthritis: fibrodysplasia ossificans progressiva (FOP) in monozygotic twins presenting to rheumatology clinic","volume":"36","author":"Jha","year":"2025","journal-title":"Mediterr J Rheumatol"},{"issue":"5","key":"2026090813220445900_ref43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3941\/jrcr.v15i5.4103","article-title":"Fibrodysplasia ossificans progressiva (FOP) presenting as a rapidly growing non-calcified neck mass","volume":"15","author":"Yamin","year":"2021","journal-title":"J Radiol Case Rep"},{"issue":"1","key":"2026090813220445900_ref44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1044\/1059-0889(1999\/011)","article-title":"Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva","volume":"8","author":"Levy","year":"1999","journal-title":"Am J Audiol"},{"key":"2026090813220445900_ref45","volume-title":"The International Clinical Council on Fibrodysplasia Ossificans Progressiva","year":"2024"},{"issue":"5","key":"2026090813220445900_ref46","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1542\/peds.2005-0469","article-title":"Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva","volume":"116","author":"Kitterman","year":"2005","journal-title":"Pediatrics."},{"issue":"8","key":"2026090813220445900_ref47","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/genes12081187","article-title":"Fibrodysplasia ossificans progressiva: a challenging diagnosis","volume":"12","author":"De Brasi","year":"2021","journal-title":"Genes (Basel)"},{"issue":"C","key":"2026090813220445900_ref48","doi-asserted-by":"publisher","first-page":"109548","DOI":"10.1016\/j.ijscr.2024.109548","article-title":"Fibrodysplasia ossificans progressiva: a rare disease due to unawareness, case report and literature review","volume":"117","author":"Guyolla","year":"2024","journal-title":"Int J Surg Case Rep"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag125\/70634239\/ziag125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/10\/ziag125\/70634239\/ziag125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/10\/ziag125\/70634239\/ziag125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:22:08Z","timestamp":1788888128000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag125\/8761071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag125","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,13]]},"article-number":"ziag125"}}